BioCentury
ARTICLE | Company News

Schering in-licenses Rho kinase inhibitor IP

September 20, 2004 7:00 AM UTC

Morphochem (Munich, Germany) and Migragen (Tuebingen, Germany) sold their joint rights to a patent application covering Rho kinase inhibitors to Schering (FSE:SCH; SHR). Migragen, which filed for inso...